Nvidia will spend more than $ 100 million on its Cambridge-1 supercomputer. This sum is the starting point, according to Jensen Huang, CEO of Nvidia, who mentioned this sum during the Six Five Summit, as reported by Reuters.
Last October, Nvidia gave a bit of detail about the outlines of this supercomputer which is due to see the light of day in Cambridge. Intended for medical research in the UK Cambridge-1 should be operational by the end of the year. At first, Nvidia announced an investment of £ 40million (around $ 55.6million). An amount that has almost doubled in the space of just a few months. Jensen Huang mentioned “A big investment. It’s the most powerful supercomputer in the UK, and researchers are thrilled with it.”
The machine will be powered by 80 DGX A100 systems and equipped with a computing capacity of 400 petaflops for deep learning and 8 petaflops for Linpack performance. Initially, Cambridge-1 is intended to help research on Covid-19. British pharmaceutical giants GlaxoSmithKline (GSK) and AstraZeneca will be among the first users. So are researchers from Guy’s and St Thomas’ NHS Foundation Trust, King’s College London and Oxford Nanopore Technologies.
At the same time, Nvidia wants to develop another state-of-the-art supercomputer using its GPUs and CPU Arms. This device was announced on the occasion of the acquisition of Arm, which is closely scrutinized by the competition authorities. It is to be installed in a large artificial intelligence research center, the result of an extension of Arm’s headquarters in Cambridge.